WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Friday, July 11, 2014

How would you like to Die? Would you want the Doctor's to help you or what? This is a personable one as a legal one.



Diane Rehm and her husband John had been married for 54 years when he knew he didn’t want to live another day.
His Parkinson’s disease had become unbearable. “He just kept getting weaker,” the NPR host told NBC News. “We called in the doctor and John said to him: ‘I am ready today.’ He said ‘I can no longer use my legs, I can no longer use my arms, I can no longer feed myself.’ And knowing with Parkinson’s it is going to get worse rather than better, he said ‘I wanted to die.’” He asked the doctor for help.

The answer they got surprised and disappointed both of them. “The doctor said ‘I cannot do that legally, morally or ethically’,” Rehm said. “He said ‘I don’t disagree with your wish that you could die with the help of a physician but I cannot do it in the state of Maryland.’”
John Rehm had to deliberately die by dehydration. It took nine days.
“John said he felt betrayed,” Rehm said. He said, ‘I felt that when the time came, you would be able to help me.’”


It’s just the type of death the advocacy group Compassion & Choices, among others, has been fighting to prevent. Instead, John Rehm should have had the option of an assisted death, the group says. They call for "aid in dying" — allowing mentally competent, terminally ill adults to request life-ending medication from a doctor for a peaceful and painless death. It's legal in several states, but not Maryland.

John Rehm met the definition, says Diane Rehm, a nationally syndicated talk show host for WAMU-FM in Washington.
“Both of us had agreed that when the time came, we would be there for each other in whatever way was necessary,” she said. “So when he made up his mind, that was it.”
"He simply decided the end had come and he did not want to carry on this way."
She wasn’t happy about it, but understood his decision. He’d been in assisted living since November of 2012. “That was something we had both agreed we never wanted but at that point he had started falling and I couldn’t lift him,” said Rehm.
By June of this year, John was very frail. There’s no cure for Parkinson’s, and the few available treatments eventually stop working. “He was so brave,” Rehm said. “He simply decided the end had come and he did not want to carry on this way. He could no longer feed himself, he couldn’t shower alone, he couldn’t stand alone.”
The only option, his doctor told him, was to refuse all food and water. It’s not an easy way to die, as it takes anywhere from a few days or a few weeks to succumb to dehydration. It can be very painful, causing headaches, leg cramps and delirium.

John Rehm’s doctor kept an eye on him, administering low doses of morphine to control the discomfort. “He did not seem to feel pain,” Rehm said. “We kept putting lotion on his lips and using tiny little sponges in his mouth to keep him comfortable.”

It wasn’t easy to watch. “I wanted to take applesauce and put it in his mouth,” Rehm said. “But you can’t do that. You have to respect someone else’s wishes. You have to honor his desires. And he was finished with life. He said ‘I am looking forward to the next journey’,” she added.
Polls show that 65 percent or more of the U.S. population supports having an option available to help people choose a quicker, more painless death, Compassion & Choices says. This is different from assisted suicide or euthanasia, the group stresses. “Assisted suicide is a crime in many states, including Oregon and Washington, where aid in dying is legal,” the group says.
Assisted dying is also legal in Vermont and Montana. Several other states have considered the matter.
"I have no doubt that he was terminally ill and if he was in Oregon he would have qualified for aid in dying," said Barbara Coombs Lee, president of Compassion & Choices.
He should have had better choices."
“We do not let our little animals suffer and people shouldn’t have to suffer.”
In the United States, there's strong opposition, Coombs Lee says. "There is a vocal and politically strong minority that opposes it vehemently," she said. "They have all the power in the legislatures. The combination of organized medicine and organized religion is an extremely powerful combination in the halls of our nation’s legislatures."

Compassion & Choices says it doesn't support euthanasia or "mercy killing," "because someone else — not the dying person — chooses and acts to cause death." What is called euthanasia and is legal in some European countries more closely resembles what the group calls aid in dying.
It would allow a doctor to prescribe a lethal dose of drugs for a patient to take as he or she chose. “I would like to, in every state across the country, in every city, in every county, I would very much like to see a justification, an allowance, for aid in dying,” Rehm said.
“We do not let our little animals suffer and people shouldn’t have to suffer.”
Such a method could help patients ensure that loved ones are with them if they wish. As it happened, Rehm wasn’t there in her husband’s very last moments on June 23rd.
“I spent the night there Sunday night the 22nd because I was afraid he was going to die that night and I didn’t want him to die alone,” she said. She and their dog Maxie slept beside John’s bed.
“I will hopefully someday, with the help of a kind physician, be able to end my life when I choose."
“When the caregiver arrived at about 7:30 in the morning I said ‘I’ll run home and feed Maxie and take a shower and I’ll be back’.” A doctor called her soon after and said John, who was unconscious by this time, would likely die within the next 24 hours. But before she could get back, the caregiver called. John Rehm had died. “I got there 20 minutes too late,” Rehm said.

Rehm doesn’t want that type of uncertainty for herself. “I will hopefully someday, with the help of a kind physician, be able to end my life when I choose,” she said.
“I think there are so many reasons why people choose to end their lives and I am not talking about people who are desperate, who are miserable and lonely. I am talking about people who have lived their lives and are satisfied with what they have had and are really ready to let go,” she added.
“I just think we ought to be able to create that space for ourselves where we can choose to die with dignity and with the aid of a physician.”
As for her husband, Rehm said, “I will love him and miss him forever.”

Thursday, July 10, 2014

New six-minute test could offer a way of identifying early stage Parkinson's disease for the first time



Scientists have developed a six-minute test which could give an early diagnosis of Parkinson’s disease.
Currently Parkinson’s patients only discover they have the debilitating neurological problem when the symptoms have already taken hold.
But Oxford University academics have come up with a new way of spotting the disease at an early stage.
The researchers were able to detect early Parkinson’s disease with a remarkable 85 per cent accuracy.
The technique uses an MRI scanner to monitor the neural connections in a concentrated area at the very centre of the brain.
Even at a very early stage, Parkinson’s patients had much weaker connections in the basal ganglia region of the brain, which is associated with motor control.
The study, which has been published in the journal Neurology, found that by taking 180 pictures in six minutes they could spot the poor connections.
They also found that the test had a very low chance of incorrectly diagnosing healthy people with the disease.
A new six-minute test could diagnose Parkinson's disease in its early stages. Michael J. Fox (pictured) was diagnosed with the disease in 1991


The said scans could be done on people in their fifties, the age when the condition usually begins to take hold.
Study leader Dr Clare Mackay, a psychiatrist at Oxford University, said: ‘At the moment we have no way to predict who is at risk of Parkinson’s disease in the vast majority of cases.
Currently it is only possible to diagnose Parkinson's disease when it is more advanced. Billy Connolly (pictured) was diagnosed with the disease in September last year on the same day as he was told he had cancer


Currently it is only possible to diagnose Parkinson's disease when it is more advanced. Billy Connolly (pictured) was diagnosed with the disease in September last year on the same day as he was told he had cancer
‘We are excited that this MRI technique might prove to be a good marker for the earliest signs of Parkinson’s. The results are very promising.’
Around 127,000 people in the UK are believed to have Parkinson’s, which causes tremors, slow movements and muscle rigidity.
The new test uses an MRI scanner to monitor the neural connections at the very centre of the brain. Sir Roger Bannister (pictured) has recently revealed that he has Parkinson's
The new test uses an MRI scanner to monitor the neural connections at the very centre of the brain. Sir Roger Bannister (pictured) has recently revealed that he has Parkinson's
There is currently no cure and no way of halting the disease.
But the progressive nerve cell damage produced by Parkinson’s is thought to begin long before any symptoms appear. 
Dr Mackay said: ‘We are still at least ten years away from that magic breakthrough which allows us to slow down the progression of Parkinson’s. 
'But in order to get there, we need a way of spotting the disease early on. The two things go hand in hand.’ 
And co-author Dr Michele Hu, from Oxford University’s Nuffield department of clinical neurosciences, said: ‘Because it is so sensitive, we hope that it will be able to predict who is at risk of disease before any symptoms have developed.’
Claire Bale, a spokesman for Parkinson’s UK, which funded the research, added: ‘This new research takes us one step closer to diagnosing Parkinson’s at a much earlier stage – one of the biggest challenges facing research into the condition.
‘One person every hour is diagnosed with Parkinson’s in the UK, and we hope that the researchers are able to continue to refine their test so that it can one day be part of clinical practice.’


Read more: http://www.dailymail.co.uk/health/article-2655259/New-six-minute-test-offer-way-identifying-early-stage-Parkinsons-disease-time.html#ixzz3788vJoAZ
Follow us: @MailOnline on Twitter | DailyMail on Facebook

Margie's Journal: Parkinson's Information: Studies Show Cannabis Relieves Symptoms Of Parkins...

Margie's Journal: Parkinson's Information: Studies Show Cannabis Relieves Symptoms Of Parkins...: Observational studies show cannabis relieves motor and non-motor symptoms of Parkinson’s disease. Studies focused on cannabinoid-b...

Studies Show Cannabis Relieves Symptoms Of Parkinson’s Disease




6717226053_27147b3bf4_b

Observational studies show cannabis relieves motor and non-motor symptoms of Parkinson’s disease.
Studies focused on cannabinoid-based treatments
for Parkinson’s disease have been conducted since 
the seventies, due to the important number of 
patients suffering from the illness reporting 
an improvement of their symptoms following 
the consumption of cannabis.

Motor symptoms

Motor symptoms have been at the centre of these
studies, as they constitute the most visible and
most debilitating disorders in relation with
Parkinson’s disease.
As early as the eighties, cannabinoids have been shown to alleviate dystonia, dyskinesia, and akinesia,
all of them motor symptoms which have been known to impact certain Parkinson’s patients. For
instance, controlled doses of synthetic cannabinoids have been able to reduce dyskinesia in patients
suffering
from Parkinson’s disease or Parkinsonism for years by 30%. Incidentally, medicinal cannabis as
well as cannabis extracts-based medications are already being used to treat general spasticity in the
context of other conditions such as multiple sclerosis or Gilles de la Tourette’s syndrome.

Neurodegeneration

Research focusing on the degeneration of brain cells and its resulting impact on cognitive capacities – which
is the origin of the aforementioned motor symptoms – has also been relatively active, with a few break
through studies published during the previous decade. The neuroprotective properties of cannabinoids
had already been proven on many occasions, and the impact it could have on Parkinson’s disease
was confirmed as well .
In 2004, a research laboratory injected rats with an agonist of Tetrahydrocannabinol (THC), one of the
 major psychoactive substances of cannabis, followed by the injection of a toxin triggering an animal version
of Parkinson’s. Upon testing of these rats in parallel with a control group of healthy subjects,
researchers observed that their brains were virtually indistinguishable. In a second series of tests, other
rats were this time first injected with the toxin, then with the THC agonist, with positive results as well,
 especially when THC was combined with Cannabidiol (CBD), a non-psychoactive cannabinoid known
for its medicinal properties. In human terms, the second test suggested that cannabinoids intake could
slow down the progression of the disease for several years.

Recent advances

Despite numerous studies underlining the multiple benefits of cannabis on Parkinson’s, no palliative or
curative treatment has been developed, partly due to the lack of availability of medicinal cannabis dedicated
 to research. This is why the aforementioned studies have so far been considered with relative 
caution, especially since it was observed that an excessive dose of cannabis could reverse its own effects 
and temporarily worsen some of the motor symptoms. These results were however partly linked to the 
relative inefficacy of clinical tests conducted with synthetic cannabinoids, as well as the lack of familiarity
 of the subjects tested with medicinal marijuana or cannabis extracts-based medication.
In order to bypass the legal restriction of cannabis being illegal in most countries these last two years,
 many observational studies were published, focusing on patients already self-medicating with cannabis.
The tests measured their reaction to a “dose” of medicinal cannabis, once again with positive outcomes
 in regards to motor symptoms as well as non-motor symptoms.  Patients participating to the study
 reported that a “dose” of cannabis could relieve them for a period of 2 to 3 hours.
Medical Cannabis Farm
Medical Cannabis Nursery
Finally, in March 2014, researchers from Tel-Aviv managed to show results for 22 patients suffering from Parkinson’s Disease, whose symptoms, both motor and non-motor, were relieved following the use of cannabis. The medical team registered important fluctuations in pain, sleep, and several motor symptoms, namely tremor, rigidity and bradykinesia. In addition to these results being the first study showing cannabis relieving motor and non-motor symptoms alike, no adverse effects were observed following the intake of cannabis. It is likely that these recent advances will trigger a newfound enthusiasm from the medical community to pursue research in this direction, especially since large amounts of medicinal cannabis have been unlocked for research in 
the United States.

Walking improves mood, eases fatigue in those with Parkinson's disease





Diseases and IllnessesMedical Research
Another reason to walk: Study shows benefits to Parkinson's symptoms
Study finds improved executive functioning when people with Parkinson's walk briskly
Exercise boosts quality of life for those with Parkinson's, study indicates
In yet another endorsement for getting on your feet and walking, researchers said 
Wednesday that people with mild to moderate Parkinson’s disease may improve their 
motor function, mood, fatigue levels and more by taking regular aerobic walks


“The results of our study suggest that walking may 
provide a safe and easily accessible way of improving 
the symptoms of Parkinson’s disease and improve
 quality of life,” the lead author of the study said. 
Dr. Ergun Uc of the University of Iowa and the
 Veterans Affairs Medical Center in Iowa City 
and colleagues published their findings in the
 journal Neurology.
The researchers tracked 49 people ages 50 to 80 
who had mild to moderate Parkinson’s disease. They wore electronic heart and walking 
speed monitors, and were asked to keep a diary of their exercise. Some walked in groups, 
others on their own. Their average walking speed was 2.9 mph

Over six months, improvement came in aerobic fitness, as it would for most people. But the researchers also reported improvements -- outside of those from any medication -- in motor function, fatigue levels, mood, aspects of executive function and quality of life.
The researchers concluded that people with mild to moderate Parkinson’s disease could benefit from following the federal guidelines recommending 150 minutes a week of moderate aerobic activity for people ages 18 to 65.
More work is needed, in part because this study did not include a control group, the researchers noted. But it did demonstrate that this group of people can safely take part in 
aerobic walking.

ß-ASARONE INCREASES L-DOPA IN PARKINSON'S DISEASE



Clinical and Experimental Pharmacology and Physiology [2014] Jun 7 [Epub ahead of print]
(L.Huang, M.Deng, S.Zhang, Y.Fang, L.Li)
Complete abstract : http://www.ncbi.nlm.nih.gov/pubmed/24910244

In order to increase the effect of L-dopa it is usually administered in combination with a dopa
decarboxylase inhibitor. In Sinemet, L-dopa is combined with carbidopa. In Madopar,
L-dopa is combined with benserazide. The co-administration of ß-asarone and Levodopa is
being developed as a means of improving the effect of L-dopa even further.
ß-asarone is found in the flowering plant acorus and also in asarum, which is known as wild
ginger. For more information go to Asarone : http://en.wikipedia.org/wiki/Asarone
In animal studies the use of L-dopa in combination with ß-asarone was
compared to the use of existing methods of treating Parkinson's Disease.
Dopamine levels were found to increase in the brain (in the striatum) and in
blood plasma in response to ß-asarone. The co-administration of ß-asarone
and L-dopa could also increase the levels in blood plasma of tryosine
hydroxylase, which is the enzyme responsible for the formation of L-dopa.
Altogether, ß-asarone was found to have an effect on converting L-dopa
into dopamine by modulating the activity of dopamine metabolism.
The mechanism of co-administration of ß-asarone and L-dopa is different from that of
Sinemet and Madopar in the treatment of Parkinson's Disease. So the co-administration of
ß-asarone and L-dopa may be more beneficial to Parkinson's Disease treatment than the
existing methods and so could eventually replace them.